The local injection treatment of methotrexate (MTX) for the placenta accreta

The local injection treatment of methotrexate (MTX) for the placenta accreta - MTX local injection for the placenta accreta

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013963

Enrollment

Registered

2014-05-15

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placenta accreta

Interventions

local injection treatment of MTX control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The pregnancy women with placenta accreta

Exclusion criteria

Exclusion criteria: The pregnancy women with placenta accrete undergone cesarean delivery with hysterectomy.

Design outcomes

Primary

Measure	Time frame
Reduction of the blood loss during hepatectomy.	—

Countries

Japan

Contacts

Public ContactMamoru Morikawa

Hokkaido University Graduate School of Medicine Department of Obstetrics

mmamoru@med.hokudai.ac.jp011-706-6051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026